Tha Magni

2 years ago this competitor didn't exist. Worse product. Thinner team. No depth in your space. Now it's the name your board keeps bringing up. Sunday night, 4 tabs open, back-engineering how they out-sold you that quarter. Depth lost. Clear problem-framing won. The market rewards the story over the product."AI-powered.""All-in-one.""End-to-end." Demos become feature checklists. Champions can't repeat the value. Procurement squeezes you in month 8 of 13. ACV drops 3% per quarter. No answer for the board. Win rates compress. Expansion carries the number. CAC climbs. Multiple compresses. Next board call: the question isn't growth. It's what the company is worth to someone else. New homepage, messaging, campaign. Sales playbook rebuild. CRO sprint.(You've reviewed 3 of these this year, haven't you.) None holds. The CEO is the only one who feels every leak at once. Great idea. Terrible execution. The offer underneath was never rebuilt. Tha Magni rebuilds it as one revenue system. Positioning. Demand. Conversion. Sales narrative. Expansion. Retention. Three moves. → Profile the top 20% of customers. Behavior, not logos. → Engineer the offer unkillable inside the buying committee (CMedO, CIO, COO, CFO). Saying no would be indefensible. → Rebuild landing pages, demos, sales narrative. The bar: delight the buyer. Alignment recovers every line that matters. → Higher win rates. → Stronger ACV. → Lower price sensitivity at procurement. → Better conversion efficiency. → Scalable growth economics. Behind every demo, someone decides whether to trust you with patient outcomes. Build commercial trust on that. Category leadership follows. Founded by Tha Magni. 17+ years inside Healthcare & Life Sciences. PhD-level cell biology research. CXL conversion optimization. Scientist habit stuck. Doesn't guess. Scientific method for commercial outcomes. Entry point: the Lost Deal Diagnostic.